SOURCE: annual_report_text (1).txt
CHUNK: 807 of 1106
SIZE: 610 characters
PREVIOUS: chunk_0806_annual_report_text (1).txt
NEXT: chunk_0808_annual_report_text (1).txt
------------------------------
tes and Joint Ventures are listed in note 
12.2 
and 
are 
Cyclhad 
SAS, Normandy 
Hadrontherapy SAS, Normandy Hadrontherapy 
SARL and PanTera SA/NV. Changes in equity-accounted investments are as follows: (EUR 000) 
December 31, 2022 
December 31, 2023 
As at January 1 
20 
273 
Share of profit/(loss) of equity-accounted investments 
3 
-169 
Additions 
250 
18 200 
Unrealized gain on sale of an intangible asset 
0 
0 
As at December 31 
273 
18 304 
In 2023, IBA further contributed to the capital of 
PanTera 
SA/NV 
with 
cash 
to 
purchase 
equipment from IBA and IP in kind as described 
in Note 2.4.